25 Aug 2026
Structural diversity of bidentate and tridentate pyrazole ligands: implications for catalysis and biological activityPublisher siteResearch on Chemical Intermediates, Metal complexes synthesis and properties
UniversitiesZakariae Abbaoui
Active, last published 2026
In chronic lymphocytic leukemia research
Zakariae
Abbaoui
Scholar“Research focused on Chronic Lymphocytic Leukemia Research and adjacent fields.”
Mohamed I University
Claim Your Profile4
H-index
38
Citations
Zakariae has not officially claimed their profile. If you are Zakariae, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
akariae Abbaoui is a researcher working on Chronic Lymphocytic Leukemia Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Zakariae's work has been cited 38 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Chronic Lymphocytic Leukemia Research×4Metal complexes synthesis and properties×3Lymphoma Diagnosis and Treatment×3Computational Drug Discovery Methods×3Synthesis and biological activity×3
04 · Where I am
Affiliations
Affiliation on published researchMohamed I UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
14 works30 May 2026Open access
Ibrutinib: An Irreversible Inhibitor of Bruton’s Tyrosine KinasePublisher siteJournal of Applied Sciences and Environmental Management, Chronic Lymphocytic Leukemia Research
21 Apr 2026Open access
A Comprehensive Review of Ruxolitinib: Synthetic Strategies, Enantiomeric Precision, and Clinical UtilityPublisher siteJournal of Applied Sciences and Environmental Management, Myeloproliferative Neoplasms: Diagnosis and Treatment
14 Apr 2026Open access
Umbralisib: A Dual PI3Kd/CK1 Inhibitor in Patients With Relapsed or Refractory Indolent LymphomaPublisher siteJournal of Applied Sciences and Environmental Management, Lymphoma Diagnosis and Treatment
2 Apr 2026Open access
Zanubrutinib: A Comprehensive Hybrid Review of its Design, Synthesis, Physicochemical Properties, and Therapeutic Applications with Comparative In Silico ADMET and Toxicity ProfilingPublisher siteJournal of Applied Sciences and Environmental Management, Chronic Lymphocytic Leukemia Research
13 Mar 2026Open access
Unveiling Morphine: From Pain Relief and Addiction Risks to In Silico ADMET and Toxicity ProfilingPublisher siteJournal of Applied Sciences and Environmental Management, Berberine and alkaloids research
5 Mar 2026Open access
Unveiling Celecoxib from Discovery to Clinical Applications: Insights from ADMET PredictionsPublisher siteJournal of Applied Sciences and Environmental Management, Inflammatory mediators and NSAID effects
3 Mar 2026Open access
Unveiling Pralsetinib As Selective RET Inhibitor for Precision Oncology: An In Silico ADMET and Toxicity StudyPublisher siteJournal of Applied Sciences and Environmental Management, Lung Cancer Treatments and Mutations
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Zakariae?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you